Advertisement
U.S. markets open in 3 hours 13 minutes
  • S&P Futures

    5,206.50
    -8.25 (-0.16%)
     
  • Dow Futures

    39,190.00
    -33.00 (-0.08%)
     
  • Nasdaq Futures

    18,191.00
    -40.50 (-0.22%)
     
  • Russell 2000 Futures

    2,046.80
    -3.00 (-0.15%)
     
  • Crude Oil

    82.55
    -0.17 (-0.21%)
     
  • Gold

    2,156.40
    -7.90 (-0.37%)
     
  • Silver

    25.09
    -0.17 (-0.69%)
     
  • EUR/USD

    1.0846
    -0.0031 (-0.28%)
     
  • 10-Yr Bond

    4.3400
    0.0000 (0.00%)
     
  • Vix

    14.66
    +0.33 (+2.30%)
     
  • GBP/USD

    1.2676
    -0.0053 (-0.42%)
     
  • USD/JPY

    150.5760
    +1.4780 (+0.99%)
     
  • Bitcoin USD

    63,631.70
    -4,103.93 (-6.06%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,720.60
    -1.95 (-0.03%)
     
  • Nikkei 225

    40,003.60
    +263.20 (+0.66%)
     

Is Teleflex (TFX) A Smart Long-Term Buy?

ClearBridge Investments, an investment management firm, published its “Mid Cap Growth Strategy” first quarter 2021 investor letter – a copy of which can be downloaded here. During the first quarter, the ClearBridge Mid Cap Growth Strategy outperformed the benchmark Russell Midcap Growth Index. You can view the fund’s top 5 holdings to have a peek at their top bets for 2021.

ClearBridge Investments, in its Q1 2021 investor letter, mentioned Teleflex Incorporated (NYSE: TFX), and shared their insights on the company. Teleflex Incorporated is a Wayne, Pennsylvania-based medical devices provider that currently has an $18.2 billion market capitalization. Since the beginning of the year, TFX delivered a -5.35% return, while its 12-month gains are up by 6.26%. As of June 02, 2021, the stock closed at $389.56 per share.

Here is what ClearBridge Investments has to say about Teleflex Incorporated in its Q1 2021 investor letter:

"Teleflex is a diversified medical device company with leading market share in several low-cost consumable niche categories, creating high-margin recurring revenue streams with steady growth and pricing. Its unique UroLift product has the potential to accelerate growth of the company with its strong positioning as the only minimally invasive product to treat BPH in the prostate gland with no side effects, a treatment area with a large total addressable market."

Countries With Highest Medical Research Spending
Countries With Highest Medical Research Spending

Likoper/Shutterstock.com

Our calculations show that Teleflex Incorporated (NYSE: TFX) does not belong in our list of the 30 Most Popular Stocks Among Hedge Funds. As of the end of the first quarter of 2021, Teleflex Incorporated was in 33 hedge fund portfolios, compared to 30 funds in the fourth quarter of 2020. TFX delivered a -0.36% return in the past 3 months.

The top 10 stocks among hedge funds returned 231.2% between 2015 and 2020, and outperformed the S&P 500 Index ETFs by more than 126 percentage points. We know it sounds unbelievable. You have been dismissing our articles about top hedge fund stocks mostly because you were fed biased information by other media outlets about hedge funds’ poor performance. You could have doubled the size of your nest egg by investing in the top hedge fund stocks instead of dumb S&P 500 ETFs. Here you can watch our video about the top 5 hedge fund stocks right now. All of these stocks had positive returns in 2020.

At Insider Monkey we leave no stone unturned when looking for the next great investment idea. For example, lithium mining is one of the fastest growing industries right now, so we are checking out stock pitches like this emerging lithium stock. We go through lists like the 10 best hydrogen fuel cell stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our homepage.

Disclosure: None. This article is originally published at Insider Monkey.

Advertisement